FOXM1 and intrahepatic cholangiocarcinoma: In summary, the findings from this study indicate that FoxM1 is significantly upregulated in ICC, and its overexpression is markedly associated with tumor progression and poor clinical outcomes in patients with ICC after hepatectomy.